Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05940337
Other study ID # NL70696.081.19
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 11, 2020
Est. completion date July 31, 2023

Study information

Verified date January 2024
Source Wageningen University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Aging is commonly associated with reduced functionality of the immune system, resulting in a higher prevalence of infectious disease, auto-immune disease, cancer, and lower efficiency of vaccination. Nutritional strategies are increasingly recognized as a method to improve immune functionality, as several nutrients are shown to exert immunomodulatory properties. However, the large variation between individuals with regard to immune responses asks for more personalized approaches. Therefore, this field of research would benefit from a selection of those individuals with immune dysfunction. It is recently shown that immune functionality is largely dependent on intracellular metabolism, leading to the introduction of the new term 'immune cell fitness' which combines the metabolic and functional status of an immune cell. Within this study, we will determine the immune cell fitness of monocytes from healthy young adults and elderly subjects by measuring and integrating a broad range of metabolic and functional immune parameters into an immune cell fitness score. We aim to identify those individuals with immune dysfunction, the unfit. Furthermore, to identify potential nutritional strategies to improve immune cell fitness, we will study the effects of metabolites and nutrients on the immune cell fitness status of monocytes from elderly subjects.


Description:

Rationale: Aging is commonly associated with reduced functionality of the immune system, resulting in a higher prevalence of infectious disease, auto-immune disease, cancer, and low-er efficiency of vaccination. The reduction in immune functionality is called 'immunosenescence' and is often observed in addition to a chronic state of systemic inflammation, referred to as 'inflammaging'. It is commonly believed that strategies improving immune functionality can be applied to improve healthy aging. Nutritional strategies, in particular, receive increasing attention, as several foods and nutrients are shown to exert immunomodulatory properties. Nutritional strategies focussing on the intake of polyunsaturated fatty acids have indeed shown improvements in cytokine profiles and inflammatory gene expression, but suffer from large inter-individual variation, which might be caused by differences in immune functionality. Recent studies within the field of immunometabolism have shown that immune functionality is largely dependent on intracellular metabolism, leading to the introduction of the new term ' immune cell fitness' which combines the metabolic and functional status of an immune cell. To improve the efficiency of immunomodulatory nutritional intervention strategies and work towards personalized approaches to support healthy aging, identifying individuals with reduced immune cell fitness will be crucial. Objective: The primary aim of this study is to extensively characterize immune cell fitness in the elderly population to distinguish immunologically fit elderly from the unfit. Since immune cell fitness is a new concept, we will define a good immune cell fitness state using a young adult study population. Using a follow-up visit, we will evaluate whether our measure of immune cell fitness is robust and stable over time. Furthermore, to identify potential nutritional strategies to improve immune cell fitness and work towards personalized approaches, we will study the effects of metabolites and nutrients on their ability to improve immune cell fitness in monocytes from the elderly. Study design: The study will be a cross-sectional study in which we will compare the immune cell fitness state of elderly people using young adult people to define an 'immune fit' status. Immune cell fit-ness will be measured in monocytes, which will be obtained from blood samples. Subjects will be given a standardized meal which they consume in the evening before the study visit at latest 8.00 pm. After consumption of the meal, subjects are not allowed to eat or drink anything but water. On the study day, before the start of blood sampling, a small blood sample via a finger prick is collected to measure CRP levels. CRP levels of ≥10.0 mg/L indicate severe infection and will consequently exclude the subject from participating on that specific day. The relevant subjects are asked to make a new appointment. If CRP levels are < 10 mg/L, blood sampling will continue. Blood sampling and anthropometric measurements including body weight, waist and hip circumference and a DEXA scan will be performed in each subject, after which the subjects will receive breakfast. Subjects will fill in an FFQ to gain insights into regular dietary intake. In addition, subjects will fill in questionnaires on sleep quality and general health. Elderly subjects will be contacted for a follow-up visit at least 6 months and the latest 18 months after the study visit. The study-design of the follow-up visit will be similar to the first study visit, including the standardized meal the evening before, overnight fast, blood sampling, anthropometric measurements (except for the DEXA-scan, this will only be performed as a link between immune cell fitness and fat distribution is found in the first part of the study), and questionnaires. The freshly collected blood sample will be used for our secondary aims, namely 1) to study the effects of nutrients and metabolites on immune cell fitness, and 2) to test whether our measure of immune cell fitness is robust and stable over time. Update August 2023 Based on our preliminary results, we decided to cancel the follow-up visit.


Recruitment information / eligibility

Status Completed
Enrollment 156
Est. completion date July 31, 2023
Est. primary completion date July 31, 2023
Accepts healthy volunteers
Gender All
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria: - Age 20 - 30y and 60 - 75y - BMI 18.5 - 25 kg/m2 (young adults); 20 - 30 kg/m2 (elderly) - Willing to fast overnight for 12 hours - Willing to give a blood sample - Having a general practitioner - Signed informed consent Exclusion Criteria: - Diagnosed with metabolic and/or inflammatory disease (e.g. diabetes, cardiovascular disease (with the exception of hypertension), arthritis, arthrosis, glycogen storage dis-orders and auto-immune diseases) - Current diagnosis of cancer - Regular use of medication that interferes with immune function (e.g. corticosteroids, cytokine blockers) - Regular use of medication that may interfere with metabolism (e.g. metabolic inhibitors or activators) - Use of medication that interferes with immune function and metabolism in at least one week preceding the study visit (e.g. NSAID, anti-histamines, corticosteroids) - More than 4kg weight gain or weight loss over the last 4 months - Vaccination within 3 months preceding the study visit (e.g. immunization against influ-enza, pneumonia, and travel-related infections) - Donated blood within 2 months preceding the study visit - Pregnant, lactating or wishing to become pregnant in the period between the screening and study visit (self-reported) - Regular use of hard drugs and soft drugs (i.e. weekly use) and at least no use within 2 months preceding the study visit - Excessive alcohol use (i.e. >14 units per week) - Use of cigarettes and other tobacco products - Participation in another study that involves an intervention 2 months preceding the study visit - Members of the research team - Working, or doing an internship or thesis at the division "Human Nutrition and Health", Wageningen University

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Netherlands Department of Human Nutrition & Health, Wageningen University Wageningen Gelderland

Sponsors (4)

Lead Sponsor Collaborator
Wageningen University Hycult Biotech, Mead Johnson Nutrition, Top Consortium for Knowledge and Innovation (TKI) Argi & Food

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Other Circulating immune mediators Circulating cytokines and other immune related markers in plasma 1 day
Other Glucose levels circulating glucose concentration in plasma 1 day
Other Lipid profile Circulating lipids (Triglycerides, HDL and LDL) 1 day
Other Anthropometric measures - body weight Bodyweight in kg 1 day
Other Anthropometric measures - body height bodyheight in cm 1 day
Other Anthropometric measures - WHR waist- and hip-circumference in cm 1 day
Other Anthropometric measures - DEXA Dual Energy Xray absorptiometry to measure fat distribution in percentages of total mass, total body 1 day
Other C-reactive protein Concentrations in whole blood and plasma 1 day
Other Questionnaires - FFQ Food frequency questionnaire. Results are expressed as the average amount of portions consumed weekly for each food group (e.g. bread, spread, snacks, cold meal, warm meal). 1 day
Other Questionnaires - general health General health questionnaires. Questionnaires are translated into Dutch and therefore not validated. Answers will be coded and used for analysis. Some questions include a score from 1 to 5 or 10, where low scores represent bad outcomes or not frequent, and high scores represent good outcomes or frequent. 1 day
Other Questionnaires - sleep quality Sleep quality questionnaires. Questionnaires are translated into Dutch and therefore not validated. Answers will be coded and used for analysis. Some questions include a score from 1 to 5 or 10, where low scores represent bad outcomes or not frequent, and high scores represent good outcomes or frequent. 1 day
Other Gene expression expression of metabolic and inflammatory genes in monocytes and macrophages at baseline and after stimulation with pro-inflammatory mediators. Measured using qPCR and RNAsequencing. 1 day
Primary Lactate production Lactate excretion by monocytes after ex-vivo exposure to inflammatory stimuli 1 day
Primary Cytokine production Cytokine excretion by monocytes after ex-vivo exposure to inflammatory stimuli. Measured using ELISA for IL-6, IL-1b. IL-1RA, IL-8, TNFalpha. 1 day
Secondary Phagocytosis Phagocytic capacity of monocytes. Measured using absorbed fluorescent beads and flow cytometry. 1 day
Secondary Glycolytic and oxidative capacity Glycolytic and oxidative capacity of monocytes. Measured using Seahorse Assays (Agilent). 1 day
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A